Olmesartan Medoxomil
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71209-080 -
Package NDC
71209-080-01 -
Package NDC
71209-080-04 -
Package NDC
71209-080-10 -
Application number
ANDA210682 -
SPL ID
c8a58add-6c59-47ff-94e2-12d4e6513feb -
SPL set ID
c5416a9f-1dcc-4851-bbc0-6664d22fc8fa -
UNII
6M97XTV3HD -
RxCUI
349373 -
RxCUI
349401 -
RxCUI
349405
What the source publishes
- Labeler
- Cadila Pharmaceuticals Limited
- Active ingredients
- Olmesartan Medoxomil
- Form
- TABLET, COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Olmesartan Medoxomil",
"splId": "c8a58add-6c59-47ff-94e2-12d4e6513feb",
"labels": [
{
"setId": "c5416a9f-1dcc-4851-bbc0-6664d22fc8fa",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5416a9f-1dcc-4851-bbc0-6664d22fc8fa",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5416a9f-1dcc-4851-bbc0-6664d22fc8fa"
}
],
"routes": [
"ORAL"
],
"labeler": "Cadila Pharmaceuticals Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, COATED in 1 BOTTLE (71209-080-01)",
"package_ndc": "71209-080-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20250101"
},
{
"sample": false,
"description": "90 TABLET, COATED in 1 BOTTLE (71209-080-04)",
"package_ndc": "71209-080-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20250101"
},
{
"sample": false,
"description": "500 TABLET, COATED in 1 BOTTLE (71209-080-10)",
"package_ndc": "71209-080-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20250101"
}
],
"productId": "71209-080_c8a58add-6c59-47ff-94e2-12d4e6513feb",
"useDomain": "unknown",
"dosageForm": "TABLET, COATED",
"productNdc": "71209-080",
"deaSchedule": null,
"genericName": "Olmesartan Medoxomil",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "OLMESARTAN MEDOXOMIL",
"strength": "20 mg/1"
}
],
"applicationNumber": "ANDA210682",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250101",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"6M97XTV3HD"
],
"rxcui": [
"349373",
"349401",
"349405"
],
"spl_set_id": [
"c5416a9f-1dcc-4851-bbc0-6664d22fc8fa"
],
"manufacturer_name": [
"Cadila Pharmaceuticals Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71209-080_c8a58add-6c59-47ff-94e2-12d4e6513feb"